Product Images Montelukast Sodium

This is a description of medication in chewable tablet form with the active ingredient Montelukast Sodium. The tablets are 4mg each and are typically prescribed for pediatric patients between the ages of 2-5. The medication is dispensed with a patient leaflet and should be stored at controlled room temperature, protected from moisture and light, and in its original packaging. The dosage should be determined by the accompanying circular, and the patient should keep this and all medication out of the reach of children. The manufacturer is Avkare Inc.*

This is a prescription medicine with the name Montelukast Sodium, which comes in the form of chewable tablets. Each tablet contains 5.2 mg Montelukast Sodium which is equivalent to 5 mg Montelukast. The medicine is generally prescribed to patients between 6-14 years of age. The pack contains 50 tablets (5 X 10) with a circular that shows the usual dosage. The tablets should be stored at 25°C (77°F) with excursions permitted to 15-30°C (50-86°F). The pack also warns to keep this and all drugs away from the reach of children. The drug is manufactured for AVKARE, Inc.*

Montelukast Sodium Tablets are prescription drugs that come in a unit dose of 50 tablets (5X10). The drug is suitable for adults of age 15 and above. Each tablet of the drug comprises Monfelukast Sodium which is equivalent to 10mg of Monfelukast. The user is advised to see the accompanying circular for the usual dosage. The drug must be stored at 26°C (77°F) but excursions permitted to 15-30°C (59-86°F) after protecting it from moisture and light. It is essential to keep the original package of the drug away from children's reach. The manufacturer of the drug is AVKARE, inc., Pulaski, TN 38478.*

This is a graph showing the change in height (in centimeters) over time, specifically in relation to different treatments: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo. The graph includes data from 120, 119, and 121 individuals, respectively, and spans 56 weeks of treatment. There is also a strange string of characters ("Sohoanwsno") that does not seem to be relevant to the plot.*

The text describes a chart or graph presenting the mean percent change from baseline over a period of up to 15 weeks in treatment or washout. The data relates to two treatments, a placebo and a drug called Montelukast Sodium.*